Early research (Phase 1)Study completedNCT00960492
What this trial is testing
Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma
Who this might be right for
GlioblastomaGiant Cell GlioblastomaGliosarcoma
Exelixis 26